Monkeypox Virus Infection: Analysis and Detection

Dear Colleagues,

The monkeypox outbreak is ongoing, and it has spread to non-endemic countries. More than sixty-two thousand people have been affected worldwide, although few mortalities have been reported. The WHO has declared the monkeypox virus as a global public health emergency of international concern. The monkeypox virus has been endemic in African countries for decades, but we still do not have a comprehensive understanding of it. In this context, we are launching this Special Issue in Vaccines (MDPI), and we welcome your valuable contributions in the form of impactful manuscripts focusing on the topic “Monkeypox Virus Infection: Analysis and Detection”.

PCR is the gold-standard technique for the detection of the monkeypox virus, but many countries lack testing facilities. To date, no point-of-care testing kits have been developed. Many countries have not imported their cases and have not improved their national laboratories for testing, analysis and detection.

With these issues in mind, we wish to focus to the topic “Monkeypox Virus Infection: Analysis and Detection”, and we encourage and welcome submissions of manuscripts regarding the following aspects:

1. Perspectives and reviews regarding the monkeypox virus;
2. Original or review articles regarding monkeypox virus infection: analysis and detection;
3. Case reports or case series of monkeypox with typical or atypical presentation;
4. Comparison of the different clinical samples of monkeypox-infected patients with different ct values;
5. Development and improvement of new point-of-care techniques for the detection of the monkeypox virus;
6. Comparisons of molecular and serological testing methods to detect monkeypox virus.

Dr. Ranjit Sah
Prof. Dr. Alfonso J. Rodriguez-Morales
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.